Xeris Pharmaceuticals logo
Xeris Pharmaceuticals XERS
$ 5.92 0.85%

Annual report 2025
added 03-02-2026

report update icon

Xeris Pharmaceuticals Cash Conversion Cycle 2011-2026 | XERS

Annual Cash Conversion Cycle Xeris Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
535 434 380 316 190 328 -24.2 -7.1 K - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
535 -7.1 K -618

Quarterly Cash Conversion Cycle Xeris Pharmaceuticals

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
558 463 548 - 321 491 553 - 356 327 404 - 320 250 193 - 197 - 169 - 84.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
558 84.3 349

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
117 - -24.86 % $ 820 K usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
257 $ 22.56 2.13 % $ 3.74 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
42 $ 1.43 3.62 % $ 368 M usaUSA
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
46.6 $ 327.25 2.42 % $ 42.9 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
174 $ 2.66 3.5 % $ 16.7 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
205 $ 20.4 -0.87 % $ 954 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
-172 $ 4.18 1.21 % $ 447 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
85.5 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
158 $ 24.61 5.76 % $ 3.13 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
119 $ 1.49 9.56 % $ 397 M britainBritain
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
-216 - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-1.6 K - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-101 - - $ 2.18 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
459 - - $ 2.02 B usaUSA